BGLAF:OTCMKTS
BioGaia AB
$12.20
0.00%
(0.00) 1D
Jun 24, 9:37:57 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BGLAF...
Mkt. cap
11.72B
Avg. vol.
3.00
Volume
0.00
52-wk high
$11.94
52-wk low
$10.24
Beta
2.89
Shares outstanding
98.50M
No. of employees
251
Mkt. cap
11.72B
Avg. vol.
3.00
Volume
0.00
52-wk high
$11.94
52-wk low
$10.24
Beta
2.89
Shares outstanding
98.50M
No. of employees
251
News stories
From sources across the web
Seeking Alpha
·
21 hours ago
BioGaia AB (publ) 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:BIOGY) 2026-07-20
Profile
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
About BioGaia AB
AI content may include mistakes. Learn more